Lavu Ratnakar has filed a Form 144 to sell 1,300 shares of Elevance Health, Inc., which is valued at approximately $572,000. This filing is significant as it highlights a liquidity event for Ratnakar, who is an officer at Elevance Health.

The filing, dated November 5, 2026, indicates that Ratnakar acquired these shares through restricted stock transactions earlier in 2025 and 2026. The approximate sale date is noted as the same day as the filing.

Background

Elevance Health, Inc., previously known as Anthem, Inc., operates within the hospital and medical service plans sector. The company is incorporated in Indiana and is listed on the NYSE under the SEC file number 001-16751. The recent filing is part of a series of disclosures made by Ratnakar, with previous filings dating back to March 2026.

What the Filing Says

"The filing reflects the sale of 1,300 shares, with an aggregate market value of $572,000."

Impact

This filing may impact Elevance Health's stock performance and investor sentiment, as insider sales can be perceived as a signal regarding the company's future. Other executives and shareholders in the healthcare sector may also take note of this transaction as they consider their own investment strategies.

What's Next

The filing does not say what happens next.